Skip to main content
Home
  • Affected by Cancer
  • Healthy Living
  • Clinical Best Practice
  • Research & Data
  • Publications & Resources
  • About Us
  • Home
  • Affected by Cancer
    • What is cancer
    • Cancer A-Z
    • Cancer statistics
    • Interactive body map
    • Check your cancer risk online
    • Treatment
    • Living with cancer
    • Life after cancer
    • For Aboriginal and Torres Strait Islander people
    • Cancer support organisations
    • Australian cancer trials
    • Jeannie Ferris Award
    • COVID-19 and cancer
    • Culturally and Linguistically Diverse (CALD)
    • Bladder cancer
    • Bowel cancer
    • Brain cancer
    • Breast cancer
    • Breast cancer in men
    • Breast cancer in young women
    • Cervical cancer
    • Children's Cancer
    • Endometrial cancer
    • Fallopian cancer
    • Gestational trophoblastic disease
    • Gynaecological cancers
    • Head and neck cancer
    • Kidney cancer
    • Leukaemia
    • Liver cancer
    • Lung cancer
    • Lymphoma
    • Melanoma of the skin
    • Mesothelioma cancer
    • Myeloma
    • Neuroendocrine tumours
    • Oesophageal cancer
    • Ovarian cancer
    • Pancreatic cancer
    • Prostate cancer
    • Sarcoma
    • Stomach cancer
    • Testicular cancer
    • Thyroid cancer
    • Unknown primary
    • Uterine sarcoma
    • Vaginal cancer
    • Vulval cancer
  • Healthy Living
    • Lifestyle & risk reduction
    • Screening
  • Clinical Best Practice
    • Cancer types
    • Psychosocial care
    • Multidisciplinary care
    • Cancer learning
    • Australian cancer trials
    • Consumer engagement
    • Shared follow-up care
  • Research & Data
    • Research
    • Grants and funding
    • Support for clinical trials
    • Cancer data
  • Publications & Resources
    • Cancer Australia publications
    • Position statements
    • Clinical Practice Guidelines
    • Cancer Australia websites
    • Cancer risk online tools
    • Other tools and resources
    • Podcasts
    • Subscribe to our eNewsletter
    • Glossary
  • About Us
    • Strategic Plan 2014-2019
    • Organisational structure
    • Accountability and reporting
    • Position Statements
    • Who we work with
    • Lung Cancer Screening enquiry
    • National Pancreatic Cancer Roadmap
    • News
    • Media
    • Campaigns & events
    • Information publication scheme
    • Reconciliation action plan
    • Employment opportunities
    • Contact us

Prostate cancer

prostate-mm affected-cancer/cancer-types/prostate-cancer/what-prostate-cancer
    • Home
    • Types
    • Statistics
    • Risk factors
    • Symptoms
    • Diagnosis
    • Treatment
    • Finding support
    • Clinical trials
    • Health professionals
    • Home
    • Types
    • Statistics
    • Risk factors
    • Symptoms
    • Diagnosis
    • Treatment
    • Finding support
    • Clinical trials
    • Health professionals
  1. Home
  2. Statistics

Prostate cancer in Australia statistics

  • Printer-friendly version
  • A|A

The following material has been sourced from the Australian Institute of Health and Welfare

Prostate cancer incorporates ICD-10 cancer code C61 (Malignant neoplasm of prostate).


Estimated number of new cases of prostate cancer diagnosed in 2020

male icon 16,741 males


Estimated % of all new male cancer cases diagnosed in 2020

22%


Estimated number of deaths from prostate cancer in 2020

male icon 3,152 males


Estimated % of all male deaths from cancer in 2020

12%


Chance of surviving at least 5 years (2012–2016)

95%


Males living with prostate cancer at the end of 2015 (diagnosed in the 5 year period 2011 to 2015)

89,703


New cases

Prostate cancer was the most commonly diagnosed cancer in Australia in 2016 and also the most commonly diagnosed cancer among males. It is estimated to become the second most commonly diagnosed cancer in 2020, while remaining the most commonly diagnosed cancer among males. 

In 2016, there were 19,305 new cases of prostate cancer diagnosed in Australia. In 2020, it is estimated that 16,741 new cases of prostate cancer will be diagnosed in Australia.

Figure 1. Estimated most common cancers diagnosed among males, 2020

Notes 

  • Data sourced from AIHW Cancer Data in Australia 2020 web report and supplementary data tables
  • More information about incidence rates for the most common cancers diagnosed can be found on the NCCI website in the ‘Cancer incidence’ section (https://ncci.canceraustralia.gov.au/diagnosis/cancer-incidence/cancer-incidence) 

In 2016, the age-standardised incidence rate was 141 cases per 100,000 males. In 2020, it is estimated that the age-standardised incidence rate will reduce to 110 cases per 100,000 males. The incidence rate for prostate cancer is expected to increase with age, peaking at age group 70-74, before decreasing with age after this.

Figure 2. Age-standardised incidence rates for prostate cancer, 1982 to 2016

Notes 

  • Data sourced from AIHW Cancer Data in Australia 2020 web report and supplementary data tables
  • More information about incidence rates for prostate cancer over time, by age, Indigenous status, remoteness, and socioeconomic status (SES) can be found on the NCCI website in the ‘Cancer incidence’ section (https://ncci.canceraustralia.gov.au/diagnosis/cancer-incidence/cancer-incidence) 

The number of new cases of prostate cancer diagnosed increased from 3,606 in 1982 to 19,305 in 2016. Over the same period, the age-standardised incidence rate increased from 80 cases per 100,000 males in 1982 to 141 cases per 100,000 males in 2016.

Deaths 

In 2018, prostate cancer was the third most common cause of cancer death in Australia and the second most common cause of cancer death among males. It is estimated that it will become the fourth most common cause of cancer death in Australia and remain the second most common cause of male cancer death in 2020.

In 2018, there were 3,264 deaths from prostate cancer in Australia. In 2020, it is estimated that this will decrease to 3,152 deaths.

Figure 3. Estimated most common causes of cancer death among males, 2020

Notes 

  • Data sourced from AIHW Cancer Data in Australia 2020 web report and supplementary data tables
  • More information about mortality rates for the most common causes of cancer death can be found on the NCCI website in the ‘Cancer mortality’ section (https://ncci.canceraustralia.gov.au/outcomes/cancer-mortality/cancer-mortality) 

In 2018, the age-standardised mortality rate was 24 deaths per 100,000 males. In 2020, it is estimated that the age-standardised mortality rate will be 21 deaths per 100,000 males. The mortality rate for prostate cancer is expected to increase with age.

Figure 4. Age-standardised mortality rates for prostate cancer, 1982 to 2018

Notes 

  • Data sourced from AIHW Cancer Data in Australia 2020 web report and supplementary data tables
  • More information about mortality rates for prostate cancer over time, by age, Indigenous status, remoteness, and socioeconomic status (SES) can be found on the NCCI website in the ‘Cancer mortality’ section (https://ncci.canceraustralia.gov.au/outcomes/cancer-mortality/cancer-mortality) 

The number of deaths from prostate cancer increased from 1,370 in 1982 to 3,264 in 2018. Over the same period, the age-standardised mortality rate decreased from 35 deaths per 100,000 males in 1982 to 24 deaths per 100,000 in 2018. 

Survival 

In 2012–2016, individuals diagnosed with prostate cancer had a 95% chance of surviving for five years compared to their counterparts in the general Australian population. Between 1987–1991 and 2012–2016, five-year relative survival for prostate cancer improved from 60% to 95%.

Figure 5. 5-year relative survival for prostate cancer, 1987–1991 to 2012–2016

Notes 

  • Data sourced from AIHW Cancer Data in Australia 2020 web report and supplementary data tables
  • More information about 5-year relative survival rates for prostate cancer over time, by age, Indigenous status, remoteness, and socioeconomic status (SES) can be found on the NCCI website in the ‘Relative survival rate’ section (https://ncci.canceraustralia.gov.au/outcomes/relative-survival-rate/5-year-relative-survival) 

Prevalence 

At the end of 2015, there were 18,650 males living who had been diagnosed with prostate cancer that year, 89,703 males living who had been diagnosed with prostate cancer in the previous 5 years (from 2011 to 2015) and 220,943 males living who had been diagnosed with prostate cancer in the previous 34 years (from 1982 to 2015).

For more information, see Prostate cancer on the NCCI website 

The National Cancer Control Indicators (NCCI) are a set of indicators across the continuum of cancer care, from Prevention and Screening through to Diagnosis, Treatment, Psychosocial care, Research and Outcomes.  The NCCI website allows users to see visual representations of data on each indicator through interactive charts.

  • Last Updated
  • Relevant Links
updated: 20 October 2020 - 3:32pm
Prostate Cancer Foundation of Australia
National Cancer Institute (US)
American Cancer Society, Prostate cancer: detailed guide

Related information

What is cancer?
What is cancer?

Cancer is a disease of the cells, which are the body’s basic building blocks.

Treatment and side effects
Treatment and side effects

The treatment that your doctors recommend will depend on the type of cancer you have, how advanced it is, and other personal factors.

Living with cancer
Living with cancer

A diagnosis of cancer marks the beginning of a journey full of emotional, psychological, physical and practical challenges.

Life after cancer
Life after cancer

While looking forward to finishing their cancer treatment and getting on with life, for some people, the end of treatment can also be a confusing or worrying time.

A-Z List of Cancer Types

Information on more than 70 types of cancer

  • Bladder cancer
  • Bowel cancer
  • Brain cancer
  • Breast cancer
  • Breast cancer in men
  • Breast cancer in young women
  • Cervical cancer
  • Children's Cancer
  • Endometrial cancer
  • Fallopian cancer
  • Gestational trophoblastic disease
  • Gynaecological cancers
  • Head and neck cancer
  • Kidney cancer
  • Leukaemia
  • Liver cancer
  • Lung cancer
  • Lymphoma
  • Melanoma of the skin
  • Mesothelioma cancer
  • Myeloma
  • Neuroendocrine tumours
  • Oesophageal cancer
  • Ovarian cancer
  • Pancreatic cancer
  • Prostate cancer
  • Sarcoma
  • Stomach cancer
  • Testicular cancer
  • Thyroid cancer
  • Unknown primary
  • Uterine sarcoma
  • Vaginal cancer
  • Vulval cancer

About Cancer Australia

Cancer Australia was established by the Australian Government in 2006 to benefit all Australians affected by cancer, and their families and carers. Cancer Australia aims to reduce the impact of cancer, address disparities and improve outcomes for people affected by cancer by leading and coordinating national, evidence-based interventions across the continuum of care.

If you would like an interpreter to help you understand any information on this website, please call TIS National on 131 450 and ask them to call Cancer Australia on 02 9357 9400. Our business hours are 9am to 5pm, Monday to Friday.

Freecall 1800 624 973
+61 2 9357 9400

Locked Bag 3, Strawberry Hills
NSW 2012

Navigation

  • Affected by Cancer
  • Healthy Living
  • Clinical Best Practice
  • Research & Data
  • Publications & Resources
  • About Us

Contact us

* Denotes mandatory fields
 

By submitting this form, you accept the Cancer Australia privacy policy.

  • Contact Us
  • Copyright
  • Disclaimer
  • Privacy policy
  • Sitemap
Copyright © 2021 - Cancer Australia